GOZZINI, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.717
EU - Europa 984
AS - Asia 291
AF - Africa 7
Totale 2.999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.709
RU - Federazione Russa 353
PL - Polonia 282
IE - Irlanda 104
CN - Cina 99
IT - Italia 85
SE - Svezia 85
SG - Singapore 74
HK - Hong Kong 62
JO - Giordania 21
FI - Finlandia 17
IN - India 16
GB - Regno Unito 14
CH - Svizzera 12
UA - Ucraina 12
VN - Vietnam 12
DE - Germania 11
CA - Canada 8
CI - Costa d'Avorio 6
FR - Francia 4
ID - Indonesia 3
BE - Belgio 2
ES - Italia 2
TR - Turchia 2
IL - Israele 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
Totale 2.999
Salva come PNG Salva come JPEG
Città #
Santa Clara 574
Warsaw 282
Fairfield 154
Chandler 114
Dublin 104
Woodbridge 88
Ashburn 85
Seattle 83
Cambridge 76
Houston 62
Singapore 62
Beijing 48
Hong Kong 44
Wilmington 39
Ann Arbor 35
Lawrence 29
Princeton 29
Altamura 28
Buffalo 24
Florence 20
Jacksonville 18
Shanghai 16
Boston 15
Medford 14
Bern 12
Kent 11
Mumbai 11
San Diego 11
Dong Ket 10
Boardman 9
Moscow 9
Rome 9
Dearborn 7
Norwalk 7
Abidjan 6
Turin 6
Renton 5
Toronto 5
Los Angeles 4
Notre Dame 4
Yubileyny 4
Detroit 3
Falls Church 3
Hillsboro 3
Malang 3
Phoenix 3
Pune 3
Tappahannock 3
Andover 2
Barcelona 2
Bremen 2
Brussels 2
Izmir 2
Karlskrona 2
Kochi 2
London 2
Montréal 2
Piancogno 2
Rubano 2
Salerno 2
Smolensk 2
Trumbull 2
Auburn Hills 1
Baotou 1
Belgrade 1
Castel Volturno 1
Castelliri 1
Cerignola 1
Costa Mesa 1
Cuneo 1
Gallatin 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Helsinki 1
Hounslow 1
Islington 1
Kilburn 1
Meizhou 1
Montgomery 1
New York 1
Ottawa 1
Redmond 1
Redwood City 1
Suzhou 1
Tel Aviv 1
Xuzhou 1
Yuncheng 1
Totale 2.248
Salva come PNG Salva come JPEG
Nome #
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 284
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 229
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 207
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. 155
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 146
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 140
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 136
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 135
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 135
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia 132
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. 127
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. 121
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 115
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 104
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 98
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 94
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 93
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 92
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 90
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 89
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 88
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 86
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo 80
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 72
Totale 3.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020288 0 0 0 0 0 43 46 55 44 47 44 9
2020/2021318 19 35 3 34 14 41 27 26 38 41 14 26
2021/2022171 9 12 14 9 2 6 3 12 2 13 34 55
2022/2023494 41 98 37 33 27 78 69 21 52 2 16 20
2023/2024201 10 17 24 8 15 19 9 58 3 4 19 15
2024/20251.114 44 132 99 193 424 222 0 0 0 0 0 0
Totale 3.048